Quality is Life — Laos Alliance Pharmaceutical Group

ລາວ/中文/EN

Manufacturing & innovation

Manufacturing Capabilities

Every dosage form we make

Manufacturing Network

Plants & 20 workshops

Research & Development

Labs, ATMP & formulation

Quality & GMP

Standards & traceability

Alliance Stem Cell Centre

Stem-cell, NK & exosome science

Integrated Value Chain

Farm → chemicals → finished

What we make

Every major dosage form, made to one GMP standard

Explore capabilities

/

NEWSROOM

Product news

Registrations, approvals and changes to Alliance product presentations.

ALI-LENA® Injection (lenacapavir) registered in Lao PDR

The Food and Drug Department has registered ALI-LENA® Injection (lenacapavir) 463.5 mg / 1.5 mL for subcutaneous use, indicated with other antiretrovirals for heavily treatment-experienced adults with multidrug-resistant HIV-1.

ALIVOSO® (vosoritide) registered in Lao PDR

The Food and Drug Department has registered ALIVOSO® (vosoritide) 1.2 mg powder for injection, indicated to increase linear growth in children with achondroplasia whose growth plates have not closed.

ALI-TIRZEP® (tirzepatide) registered in Lao PDR across eight presentations

The Food and Drug Department has issued certificates of drug registration for ALI-TIRZEP® (tirzepatide) in eight presentations — four single-dose and four multi-dose — manufactured by Alliance Pharmaceutical Co., Ltd in Vientiane Capital.